Globus Medical, Inc.

GMED · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$119$203$75$27
Dep. & Amort.$71$71$66$68
Deferred Tax$42-$42$1-$33
Stock-Based Comp.$12$14$13$12
Change in WC$2-$57$10$27
Other Non-Cash$5-$111$12$110
Operating Cash Flow$250$78$177$210
Investing Activities
PP&E Inv.-$36-$47-$36-$17
Net Acquisitions$255-$253$0$0
Inv. Purchases-$35$0-$2-$100
Inv. Sales/Matur.$0$0$174$13
Other Inv. Act.-$260$0-$5$0
Investing Cash Flow-$76-$299$131-$104
Financing Activities
Debt Repay.$0$0-$450$0
Stock Issued$11$0$0$0
Stock Repurch.-$40-$25-$190-$1
Dividends Paid$0$0$0$0
Other Fin. Act.-$3$0$5$61
Financing Cash Flow-$32-$25-$635$60
Forex Effect$1$14$4-$4
Net Chg. in Cash$142-$232-$323$162
Supplemental Information
Beg. Cash$229$461$784$623
End Cash$372$229$461$784
Free Cash Flow$219$31$136$193
Globus Medical, Inc. (GMED) Financial Statements & Key Stats | AlphaPilot